Bloomberg Television
@markets·3.2M subscribers·95.6K videos
Novo’s Wegovy Trial Shows Heart Benefit in Obesity Patients
Posted
November 13, 2023
Views
1,051
Likes
5
Comments
5
Engagement
November 13, 2023
1,051
5
5
0.95%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
1:48Now PlayingNovo Nordisk A/S revealed details from a key study backing the use of Wegovy, its blockbuster weight-loss drug, to cut heart attacks and deaths in obesity patients with a history of cardiovascular disease. Eric Pfanner reports on Bloomberg Television.
--------
Follow Bloomberg for business news & analysis, uptotheminute market data, features, profiles and more
Connect with us on...
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
